Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
Alyssa M Peckham, Maria J Ananickal, David A Sclar Department of Pharmacy Practice, Midwestern University College of Pharmacy-Glendale, Glendale, AZ, USA Abstract: The abuse potential of gabapentin is well documented; with gabapentin having been noted as an agent highly sought after for use in poten...
Saved in:
Main Authors: | Peckham AM (Author), Ananickal MJ (Author), Sclar DA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reclassification of English Learners
by: James B. Grissom
Published: (2004) -
Opioid-Induced Hyperalgesia in Chronic Pain Patients and the Mitigating Effects of Gabapentin
by: Nicoleta eStoicea, et al.
Published: (2015) -
Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study
by: Abisola Olopoenia, et al.
Published: (2022) -
Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
by: Alyssa M Peckham, et al.
Published: (2018) -
The Comparison of Alexithymia and Emotions Control among Substance Abusers and Healthy People
by: M.J Bagyan Kouleh Marz, et al.
Published: (2014)